Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes.

Michael BöttcherHans-Dirk DüngenVasile CorceaFrank DonathRainard FuhrPim GalGerd MikusDietmar TrenkMartin CoenenPhilippe Vieira PiresClaudia MaschkeAntonios Othon AliprantisNina BescheCorina Becker

Published in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2023)

ClinicalTrials.gov number, NCT03504982.

Keyphrases

placebo controlled
double blind
clinical trial
coronary artery disease
phase ii
coronary artery
study protocol
phase iii
phase ii study
randomized controlled trial
heart failure
radiation therapy